ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

JSPR Jasper Therapeutics Inc

25.30
0.96 (3.94%)
Jun 14 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 72,416
Bid Price 24.55
Ask Price 25.30
News -
Day High 25.245

Low
4.00

52 Week Range

High
31.01

Day Low 23.90
Company Name Stock Ticker Symbol Market Type
Jasper Therapeutics Inc JSPR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.96 3.94% 25.30 18:17:05
Open Price Low Price High Price Close Price Prev Close
24.40 23.90 25.245 25.02 24.34
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,720 72,416 $ 24.38 $ 1,765,686 - 4.00 - 31.01
Last Trade Time Type Quantity Stock Price Currency
19:57:30 1 $ 24.56 USD

Jasper Therapeutics (JSPR) Options Flow Summary

Overall Flow

Bullish

Net Premium

27k

Calls / Puts

100.00%

Buys / Sells

100.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Jasper Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
377.5M 15.06M - 0 -64.47M -4.28 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Jasper Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No JSPR Message Board. Create One! See More Posts on JSPR Message Board See More Message Board Posts

Historical JSPR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week24.886425.4023.3624.1793,5070.41361.66%
1 Month22.8026.83522.13524.42103,0062.5010.96%
3 Months30.0631.0120.1524.8082,614-4.76-15.83%
6 Months4.35831.014.23513.23195,38620.94480.54%
1 Year17.4031.014.009.81318,5337.9045.40%
3 Years140.60188.803.86256.48791,555-115.30-82.01%
5 Years140.60188.803.86256.48791,555-115.30-82.01%

Jasper Therapeutics Description

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.